12 Best Major Stocks to Buy According to Billionaires
The U.S. stock market had one of the worst starts, at least the worst start to a presidency since 1928.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,438,446 | $4,491,667,635 | +4% | 1.94% |
| 2. | GQG Partners Rajiv Jain | 1,829,453 | $1,510,963,352 | -60% | 2.41% |
| 3. | Egerton Capital Limited John Armitage | 492,808 | $407,015,055 | +76% | 4.7% |
| 4. | Hudson Bay Capital Management Sander Gerber | 391,083 | $322,999,361 | +47% | 1% |
| 5. | 203,100 | $167,742,321 | -37% | 0.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $818.24 | 1,000 | Officer | 5,840 | 2025-03-13 | Filing | |
| $934.89 | 812 | 96,016,978 | 2025-03-03 | Filing | ||
| $933.74 | 3,997 | 96,017,790 | 2025-03-03 | Filing | ||
| $932.77 | 10,699 | 96,021,787 | 2025-03-03 | Filing | ||
| $931.82 | 17,393 | 96,032,486 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 101,288,687 | $83,655,339,481 | 43.8% | |
| 2. | 96,016,978 | $79,301,382,300 | 100% | |
| 3. | 79,224,392 | $65,432,217,584 | 1.18% | |
| 4. | 65,691,973 | $54,255,657,747 | 1.14% | |
| 5. | 28,468,668 | $23,512,558,506 | 1.5% |
News See All
13 Stocks on Jim Cramer’s Radar Recently
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
10 Best Income Stocks to Invest in Now
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Eli Lilly and Company (LLY): A Bull Case Theory
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY.
Eli Lilly and Company (NYSE:LLY) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
15 Best Growth Stocks to Buy for the Next 3 Years
On April 29, Dan Ives of Wedbush Securities joined 'Power Lunch' on CNBC to discuss his outlook for the tech sector and expressed that tariffs aren't stopping the AI revolution.
How Did Jim Cramer’s 12 Bold Predictions Play Out?
During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial intelligence stocks, three months after the emergence of DeepSeek, a Chinese AI firm that initially...
Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus
Still, Cramer warned that the real challenge lies ahead, as the market now enters another week where important earnings are reported.
10 Best Long-Term Dividend Stocks to Buy According to Billionaires
Dividend stocks are increasingly popular with both every day and billionaire investors.
Billionaire Hedge Funds
